Capillary Technologies India Ltd
Q4 FY27 Earnings Call Analysis
IT - Software
orderbook: Yesfundraise: No informationcapex: Yesrevenue: Category 2margin: Category 3
ποΈcapex
Any current/future capex/capital investment/strategic investment?
- Capillary is continuing investments in AI product development, which has been delivering good results and improving productivity for both Capillary and its customers.
- Ongoing investment in product enhancements to facilitate smoother customer migrations from legacy platforms to the Capillary platform, particularly for acquired customers.
- No new products are currently planned, but the company will update stakeholders as and when new products are developed.
- Technology and corporate costs, which form a significant part of expenses, have decreased as a percentage of revenue, indicating ongoing investment efficiency.
- The company has made acquisitions (fourth acquisition being Kognitiv in May) and plans further M&A activity, focusing on migrating acquired customers to Capillaryβs platform to realize margin and efficiency gains.
πrevenue
Future growth expectations in sales/revenue/volumes?
- Revenue grew 16% year-on-year in Q3 FY26, with 22% growth for the nine months period.
- Annual Recurring Revenue (ARR) increased by 21% over March 2025 for the nine months FY26.
- New order book increased from INR 53 crores to INR 66 crores in the first nine months, indicating growth in new customer wins.
- Net Retention Rate (NRR) for organic customers at 115%, demonstrating strong expansion within the existing customer base.
- 12 new customers added over nine months, with three in the last quarter.
- Growth driven by three axes: strong net retention, new customer acquisition, and M&A-driven customer migration.
- M&A strategy involves acquiring low-margin competitors and migrating their customers onto higher-margin Capillary platform to improve revenues and margins.
- Capillary continues to invest in AI and product innovation (e.g., aiRA) to boost win rates and enter adjacent markets, potentially enhancing future revenue streams.
πmargin
Future growth expectations in earnings/operating earnings/profits/EPS?
- EBITDA improved significantly from -4% in FY23 to about 12% in FY25 and is expected to continue improving due to economies of scale.
- Technology and corporate costs have reduced from 28% of revenue to about 18%, indicating further leverage potential.
- Majority of costs (~60%) are fixed (tech, product, sales, marketing) and expected to grow near inflation plus team growth, supporting margin expansion.
- Continued investments in AI-led product enhancements and customer migrations are planned, balancing growth and cost control.
- New customer additions and organic net retention rate (NRR) of 115% indicate strong revenue growth and margin improvement.
- Acquisitions will continue with margin-enhancing customer platform migrations driving profitability.
- Overall, profitable growth with improving EBITDA margins and operating leverage is expected, with PAT normalized for one-time costs showing stability and potential for growth.
πorderbook
Current/ Expected Orderbook/ Pending Orders?
- Over the first nine months of FY26, Capillary Technologies added 12 new customers.
- In the last quarter alone, 3 new customers were added.
- New order book value added over the 9-month period is INR 66 crores.
- This represents growth compared to INR 53 crores new order book added in the same period last year.
- The company continues to grow its new order book steadily, indicating a healthy pipeline of new business.
π°fundraise
Any current/future new fundraising through debt or equity?
- The transcript provided (up to page 16) does not mention any current or planned future fundraising through debt or equity.
- No explicit discussion on raising new capital via debt or equity is noted in the Q&A or management commentary.
- The company highlights a strong cash position with INR 463 crores cash balance and positive operating cash flows.
- Focus appears to be on organic growth, product investments, and acquisitions rather than new fundraising rounds.
- No specific disclosures or guidance regarding fundraising plans are provided in the material reviewed.
